Ninjacof Dosing for a 34-Pound Child
For a 34-pound (15.4 kg) child, the recommended dose of Ninjacof is 1 teaspoonful (5 mL) every 6 to 8 hours, not to exceed 4 teaspoonfuls in 24 hours. 1
Dosing Rationale
The FDA-approved labeling for Ninjacof specifies that children 6 to under 12 years of age should receive 1 teaspoonful (5 mL) every 6 to 8 hours, with a maximum of 4 teaspoonfuls in 24 hours. 1
A 34-pound child falls into the 6-to-under-12-years age bracket for most cough and cold preparations, as this weight typically corresponds to children in this age range. 1
Children under 6 years of age require consultation with a physician before administering Ninjacof. 1 If this 34-pound child is younger than 6 years, medical consultation is mandatory before dosing.
Important Safety Considerations
Age Verification Critical
- The weight alone does not determine appropriate dosing—age must be confirmed. 1 A 34-pound child could be a large 4-year-old (requiring physician consultation) or a small 8-year-old (appropriate for standard dosing).
Dextromethorphan Toxicity Risk
Dextromethorphan overdose in young children (especially those ≤4 years) can cause severe neurotoxicity, including cerebellar edema and profound unresponsiveness. 2 This recently described syndrome (DANCE—dextromethorphan-associated neurotoxicity with cerebellar edema) emphasizes the critical importance of proper dosing in young children.
Doses exceeding 7.5 mg/kg warrant emergency department evaluation due to risk of significant toxicity. 3 For a 15.4 kg child, this threshold is approximately 115 mg—well above the recommended single dose but achievable if dosing errors occur.
Symptoms requiring immediate medical attention include more than mild effects (excessive vomiting, significant sedation, respiratory depression, or seizures). 3
Dosing Pitfalls to Avoid
Never exceed the maximum daily dose of 4 teaspoonfuls (20 mL) in 24 hours for children in this weight range. 1
Do not use activated charcoal at home for suspected overdose—this should only be administered by healthcare professionals in appropriate settings. 3
Avoid co-administration with medications that may interact with dextromethorphan, particularly monoamine oxidase inhibitors or selective serotonin reuptake inhibitors, which can precipitate serotonin syndrome. 3